Amundi
SANA icon

Amundi’s Sana Biotechnology SANA Stock Holding History

Amundi’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-279
Closed -$382 – 2085
2025
Q1 		$382 Buy
+279
New +$780 ﹤0.01% 2140
2023
Q4 		– Sell
-7,881
Closed -$26.4K – 2067
2023
Q3 		$26.4K Hold
7,881
– – ﹤0.01% 1912
2023
Q2 		$47.6K Hold
7,881
– – ﹤0.01% 1901
2023
Q1 		$25.5K Sell
7,881
-19,458
-71% -$77.7K ﹤0.01% 1948
2022
Q4 		$120K Buy
27,339
+19,458
+247% +$95.2K ﹤0.01% 1580
2022
Q3 		$49K Buy
+7,881
New +$56.9K ﹤0.01% 1674
2022
Q2 		– Sell
-10,209
Closed -$89K – 1708
2022
Q1 		$89K Buy
+10,209
New +$82.5K ﹤0.01% 1486

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amundi's SANA Position: Q2 2025 in Review

Amundi sold out of Sana Biotechnology (SANA) in Q2 2025, closing a stake of 279 shares — an estimated $382 sold.

Amundi first reported a position in SANA in Q1 2022 and held it in 7 quarters. The position peaked at $120K in Q4 2022. 155 funds tracked by Wall St. Rank hold SANA as of Q2 2025.

  • Amundi reported no remaining Sana Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 279 Sana Biotechnology shares in Q2 2025, an estimated $382.
  • Amundi first reported a position in Sana Biotechnology in Q1 2022 and held it in 7 quarters.
  • Amundi's Sana Biotechnology position peaked at $120K in Q4 2022.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.